[Safety analysis of Allergovit immunotherapy in patients of allergic rhinitis].
OBJECTIVE
To analyse the safety of Allergovit immunotherapy in patients of allergic rhinitis.


METHODS
Two hundred and fifty-six patients with allergic rhinitis received Allergovit immunotherapy, their local and systemic side-effect were observed, recorded and analyzed during the treatment.


RESULTS
The number of patients who got local side-effect was 84 cases, the percent of local side-effect was 4.45%; the number of patients who got systemic side-effect were 21 cases, the percent of systemic side-effect was 0.31%. Both side-effects were slight.


CONCLUSIONS
Allergovit immunotherapy is a safe and feasible choice for allergic rhinitis. While the schedule fit for Chinese or individually is needed to be mended in practice.
Chen
Jianjun
J
Department of Otorhinolaryngology, Union Hospital, Huazhong University of Science and Technology, Wuhan, 430022. jj-c@tom.com
Xiang
Jisheng
J
Kong
Weijia
W
Shu
Hong
H
Shi
Qiumei
Q
Tan
Huifang
H
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000628:therapy; D008297:Male; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D014612:Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D055815:Young Adult
D014612:Vaccines; C099681:allergovit